The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research | 2020-08-15 | PMID 32430479
McCuaig Sarah, Barras David, Mann Elizabeth H and 11 more
